We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 12.47%
3 Healthcare 12.1%
4 Financials 11.43%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWL icon
2626
Powell Industries
POWL
$7.48B
$72.6K ﹤0.01%
+7,386
New +$66.3K
CLR
2627
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$72K ﹤0.01%
1,608
SGC icon
2628
Superior Group of Companies
SGC
$209M
$71.9K ﹤0.01%
3,277
GBIO
2629
DELISTED
Generation Bio
GBIO
$71.7K ﹤0.01%
1,013
-185
-15% -$32.3K
ESTE
2630
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$71.4K ﹤0.01%
+6,524
New +$69.6K
RRGB icon
2631
Red Robin
RRGB
$186M
$71K ﹤0.01%
4,298
-669
-13% -$12.8K
ITIC
2632
Investors Title Co
ITIC
$531M
$71K ﹤0.01%
360
SSTI icon
2633
SoundThinking
SSTI
$108M
$70.9K ﹤0.01%
2,402
RMNI icon
2634
Rimini Street
RMNI
$470M
$70.6K ﹤0.01%
11,829
+1,487
+14% +$11.7K
LE icon
2635
Lands' End
LE
$393M
$70.5K ﹤0.01%
3,592
VKTX icon
2636
Viking Therapeutics
VKTX
$3.84B
$70.4K ﹤0.01%
15,299
-2,780
-15% -$15.6K
GTHX
2637
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$70.1K ﹤0.01%
6,866
-1,576
-19% -$20.1K
LUNA
2638
DELISTED
Luna Innovations Incorporated
LUNA
$70.1K ﹤0.01%
8,303
+1,288
+18% +$11.6K
FHB icon
2639
First Hawaiian
FHB
$3.39B
$70.1K ﹤0.01%
2,564
-24
-0.9% -$670
NUVL
2640
DELISTED
Nuvalent
NUVL
$69.8K ﹤0.01%
3,665
+360
+11% +$8.02K
KALV
2641
DELISTED
KalVista Pharmaceuticals
KALV
$69.8K ﹤0.01%
5,274
FOSL icon
2642
Fossil Group
FOSL
$330M
$69.6K ﹤0.01%
6,760
-3,081
-31% -$37.3K
URG
2643
Ur-Energy
URG
$537M
$69.5K ﹤0.01%
56,995
BNFT
2644
DELISTED
Benefitfocus, Inc.
BNFT
$69.5K ﹤0.01%
6,522
-200
-3% -$2.15K
PKE icon
2645
Park Aerospace
PKE
$802M
$69.5K ﹤0.01%
5,266
-124
-2% -$1.67K
PAMT
2646
PAMT Corp
PAMT
$282M
$69.4K ﹤0.01%
+1,956
New +$61.2K
CTLP
2647
DELISTED
Cantaloupe
CTLP
$69.4K ﹤0.01%
7,817
-3,674
-32% -$36.6K
EGIO
2648
DELISTED
Edgio, Inc. Common Stock
EGIO
$68.5K ﹤0.01%
499
+240
+93% +$28.5K
GHL
2649
DELISTED
Greenhill & Co., Inc.
GHL
$68.4K ﹤0.01%
+3,813
New +$65.6K
INSG icon
2650
Inseego
INSG
$77.7M
$68.1K ﹤0.01%
1,168
-273
-19% -$17.7K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.